Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany

Drug budget and prescription control measures are implemented regionally in Germany, meaning that the uptake of pharmaceuticals, including biosimilars, can vary by region. We examine regional market dynamics of tumor necrosis factor alpha (TNFα) inhibitor originators and biosimilars in Germany and s...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Evelien Moorkens, Teresa Barcina Lacosta, Arnold G. Vulto, Martin Schulz, Gabriele Gradl, Salka Enners, Gisbert Selke, Isabelle Huys, Steven Simoens
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI AG 2020-10-01
Serie:Pharmaceuticals
Ämnen:
infliximab
etanercept
TNFα inhibitors
biologics
biosimilars
Germany
Länkar:https://www.mdpi.com/1424-8247/13/10/324
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk